InvestSMART

Medibank Private Limited (ASX: MPL) - Announcements

- Current share price for MPL : $4.970

ASX company news and announcements for Medibank Private Limited (MPL) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Medibank Private Limited (MPL) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Medibank Private Limited (MPL), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Medibank Private Limited (MPL)

Market Cap ($m) Headline Release
date/time+
Price at
release+
Current
price+
Gain/Loss View
$13,687 Change in substantial holding 16 May 2025 4:34PM $4.740 $4.970 risen by 4.85%
$13,687 FY25 Full Year - Key Dates 16 May 2025 8:50AM $4.730 $4.970 risen by 5.07%
$13,687 Medibank shares business update and healthcare insights 6 May 2025 8:28AM $4.670 $4.970 risen by 6.42%
$13,687 2022 cybercrime event - consumer class action 4 Apr 2025 12:45PM $4.620 $4.970 risen by 7.58%
$13,687 Notification of cessation of securities - MPL 3 Apr 2025 8:22AM $4.600 $4.970 risen by 8.04%
$13,687 Becoming a substantial holder 25 Mar 2025 4:37PM $4.390 $4.970 risen by 13.21%
$13,687 HY25 Results - Investor Presentation 27 Feb 2025 8:08AM $4.020 $4.970 risen by 23.63%
$13,687 HY25 Results - Media Release 27 Feb 2025 8:08AM $4.020 $4.970 risen by 23.63%
$13,687 Dividend/Distribution - MPL 27 Feb 2025 8:07AM $4.020 $4.970 risen by 23.63%
$13,687 HY25 Results - Appendix 4D and Financial Report 27 Feb 2025 8:07AM $4.020 $4.970 risen by 23.63%
$13,687 Medibank to return $160m to customers 27 Feb 2025 8:07AM $4.020 $4.970 risen by 23.63%
$13,687 Government approves health insurance premium increase 26 Feb 2025 6:42PM $4.020 $4.970 risen by 23.63%
$13,687 Notification of cessation of securities - MPL 8 Jan 2025 8:24AM $3.820 $4.970 risen by 30.10%
$13,687 FY25 Half Year - Key Dates 18 Dec 2024 8:16AM $3.780 $4.970 risen by 31.48%
$13,687 Change of Director's Interest - David Koczkar 13 Dec 2024 8:39AM $3.740 $4.970 risen by 32.89%
$13,687 Notification regarding unquoted securities - MPL 13 Dec 2024 8:27AM $3.740 $4.970 risen by 32.89%
$13,687 Change of Director's Interest - David Koczkar 27 Nov 2024 8:21AM $3.720 $4.970 risen by 33.60%
$13,687 Amended Constitution 13 Nov 2024 1:52PM $3.715 $4.970 risen by 33.78%
$13,687 Results of the 2024 Annual General Meeting 13 Nov 2024 1:46PM $3.710 $4.970 risen by 33.96%
$13,687 2024 AGM Chair and CEO Address 13 Nov 2024 8:41AM $3.740 $4.970 risen by 32.89%
$13,687 Change in substantial holding 25 Oct 2024 8:19AM $3.680 $4.970 risen by 35.05%
$13,687 Notification of cessation of securities - MPL 4 Oct 2024 9:08AM $3.620 $4.970 risen by 37.29%
$13,687 Proxy Form 2024 13 Sep 2024 8:31AM $3.830 $4.970 risen by 29.77%
$13,687 Notice of Annual General Meeting 2024 13 Sep 2024 8:31AM $3.830 $4.970 risen by 29.77%
$13,687 Appendix 4G 13 Sep 2024 8:30AM $3.830 $4.970 risen by 29.77%

51 - 75 of 488 results

Page 3 of 20

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.